Best Medications for Anxiety and OCD
For anxiety and OCD, SSRIs are the first-line pharmacological treatment, with sertraline being the preferred option due to its favorable side effect profile, low potential for drug interactions, and established efficacy. 1
First-Line Medications
For Anxiety Disorders:
- SSRIs (Selective Serotonin Reuptake Inhibitors)
For OCD:
- SSRIs at higher doses than used for anxiety or depression 4
Treatment Algorithm
Initial Treatment:
- Start with an SSRI (preferably sertraline) at a low dose
- For anxiety: Begin with sertraline 25-50 mg daily
- For OCD: Begin with sertraline 50 mg daily, with plan to increase 4
Dose Titration:
- For anxiety: Increase dose as tolerated at 1-2 week intervals for shorter half-life SSRIs (sertraline) or 3-4 week intervals for longer half-life SSRIs (fluoxetine) 4
- For OCD: Higher doses are typically required; increase gradually to minimize side effects 4
- Target dose for OCD: Sertraline 200 mg or fluoxetine 40-60 mg 4, 5
Duration of Trial:
Maintenance Treatment:
Treatment-Resistant Cases
If inadequate response to first-line SSRI treatment:
- Switch to another SSRI 4
- Consider clomipramine: Effective for OCD but has more side effects than SSRIs 4, 7
- Augmentation strategies:
Important Considerations
Side Effects:
Monitoring:
Discontinuation:
Special Considerations for OCD
- OCD often requires higher SSRI doses than those used for depression or anxiety disorders 4
- Response may be slower in OCD compared to depression, requiring patience with the treatment regimen 4, 9
- Combination of medication with cognitive-behavioral therapy (particularly exposure and response prevention) provides superior outcomes 4, 8
Pitfalls to Avoid
- Underdosing: OCD typically requires higher SSRI doses than depression or anxiety 4
- Premature discontinuation: Evaluate efficacy after adequate duration (8-12 weeks) 4
- Ignoring drug interactions: Particularly with fluvoxamine and citalopram 4
- Abrupt discontinuation: Can lead to withdrawal symptoms, especially with shorter-acting SSRIs 4, 1